Skip to main content
. 2008 Dec 29;3(12):e4031. doi: 10.1371/journal.pone.0004031

Figure 1. Mean PCV according to treatment group (AQ+SP: amodiaquine+sulphadoxine-pyrimethamine and CD+A: chlorproguanil-dapsone+artesunate), G6PD status (deficient: hemizygous males and homozygous females) and day of follow-up.

Figure 1